pH Effect on blastocyst formation
Otherto investigate which pH is suitable for each stage of embryo development
NCT Number: NCT03641014
Any drift in extracellular pH (pHe) from the intercellular pH (pHi) could alter the mechanism regulating transporters and exchangers through the plasma membrane. This could lead to difficulty in restoring the physiological level of pHi. The critical stages that lack robust mechanism of regulating the pHi are the denuded oocyte, early stage of fertilization or a thawed embryo. This, in turn, could lead to a significant effect of the perturbations on embryo development. Convincing evidence regarding the optimal pHe for culturing human embryo is, so far, scanty and mostly anecdotal. The embryo has been reported to have a compensatory mechanism to grow at pHe between 7.0-7.4. Others have recommended that embryo need a sequential pH to viably grow suggesting that the post-genomic activation stage needs a slightly alkaline range of pH. However, whether this holds true remains to be examined.
Looking for future studies?
Notify Me18 year–40 year
Female
Interventional
Not applicable
Quena IVF Centre, Quena, Qena Governorate, Egypt
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
to investigate which pH is suitable for each stage of embryo development
Time frame: 12 weeks
women with continued pregnancy at week 12 of gestation
Time frame: 6 days of culture
number of blastocysts suitable for transfer on day 5 or 6
Time frame: 6 days of culture
number of formed blastocyst per Fertilized oocyte
Time frame: 3 months
number of women with ultrasound detection of sacs with heartbeat per stimulated cycle
Time frame: 7 weeks
number of sacs with a heartbeat
Ibn Sina Hospital
Other Gov
Sequential pH Effect on Blastocyst Formation Rate
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06659692
Genital Diseases, Infertility
Toronto, Ontario, Canada
View Trial DetailsNCT06924437
Abnormal Uterine Bleeding (AUB), Endometrial Polyp
Sohag, Egypt
View Trial DetailsNCT01511588
Adolescents, Amenorrhea
Bethesda, Maryland, United States
View Trial DetailsNCT07399535
Adnexal Diseases, Cysts
Karachi, Sindh, Pakistan
View Trial Details